BioCentury
ARTICLE | Clinical News

OraQuick Ebola rapid antigen test regulatory update

October 5, 2015 7:00 AM UTC

FDA granted emergency use authorization (EUA) for OraSure’s OraQuick Ebola rapid antigen test to detect Ebola Zaire virus in response to the Ebola outbreak in West Africa. The diagnostic utilizes OraQ...